Carisma Therapeutics, Inc. (CARM)

0.0005 0.00 (0.00%) USD  |  OTCM  |  Apr 27, 16:00
More

Carisma Therapeutics EPS Diluted (Quarterly) : 1.066 for Sept. 30, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for CARM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
THC Therapeutics, Inc. --
TransGlobal Assets, Inc. 0.00
Cantabio Pharmaceuticals, Inc. --
Affymax, Inc. --
Scopus Biopharma, Inc. --

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) 44.72M
Revenue (Quarterly) 45.25M
Total Expenses (Quarterly) 0.533M
Enterprise Value -1.994M
Profit Margin (Quarterly) 98.82%
Earnings Yield 37.62K%
Operating Earnings Yield 51.88K%
Normalized Earnings Yield 40720.00